NASDAQ: VINCVincerx Pharma Inc Stock Ownership - Who owns Vincerx Pharma?
Insider buying vs selling
Have Vincerx Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alexander A. Seelenberger | Officer | 2023-08-11 | 10,500 | $0.95 | $9.96kBuy |
| Ahmed Md Hamdy | President and Chief Operations Officer | 2023-08-10 | 5,400 | $0.96 | $5.17kBuy |
| Raquel E. Izumi | President and Chief Operations Officer | 2023-08-10 | 3,440 | $0.93 | $3.20kBuy |
| Tom C. Thomas | President and Chief Operations Officer | 2023-08-10 | 5,000 | $0.95 | $4.75kBuy |
| Ahmed Md Hamdy | President and Chief Operations Officer | 2023-08-09 | 16,900 | $0.95 | $15.99kBuy |
| Raquel E. Izumi | President and Chief Operations Officer | 2023-08-09 | 13,036 | $0.90 | $11.73kBuy |
VINC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VINC insiders and whales buy or sell their stock.
VINC Shareholders
What type of owners hold Vincerx Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rubric Capital Management LP | 9.84% | 2,107,000 | $2.00M | Insider |
| Ahmed Md Hamdy | 8.77% | 1,878,679 | $1.78M | Insider |
| Raquel E. Izumi | 8.35% | 1,787,187 | $1.70M | Insider |
| Goldman Sachs Group Inc | 7.98% | 1,709,656 | $1.62M | Institution |
| Sage Rhino Capital LLC | 7.95% | 1,703,413 | $1.62M | Institution |
| Michael Yehuda Rice | 7.94% | 1,701,000 | $1.62M | Insider |
| Andrew I. McDonald | 7.64% | 1,636,942 | $1.56M | Insider |
| John C. Byrd | 7.56% | 1,618,199 | $1.54M | Insider |
| Long Focus Capital Management LLC | 5.13% | 1,098,753 | $1.04M | Institution |
| Bank Of America Corp | 5.06% | 1,082,863 | $1.03M | Institution |
VINC vs Biotech Stocks
Vincerx Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.